Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000271350 corresponds to a **pseudogene** of the ArsA arsenite transporter, ATP-binding, homolog 1, known as an inactive genomic sequence derived from the bacterial ArsA ATPase. While functional **ArsA** (in prokaryotes and a few eukaryotes) forms part of a transporter complex (ArsAB) that catalyzes the ATP-dependent efflux of arsenite and antimonite to confer arsenic resistance[5][4], in humans **ENSG00000271350 is a a pseudogene and does not encode a functional protein**[2]. There is no evidence that this pseudogene produces a transporter, has physiological function, or represents a therapeutic target. Key details: - **Pseudogene:** It is explicitly listed as a pseudogene in current genomic databases[2][1]. - **Not a therapeutic target:** No known transporter, enzyme, or receptor is produced by this locus in humans. There is no evidence of involvement in disease, drug interaction, or biological function[2][1]. - **No biological or disease roles:** Its bacterial homologue is important in arsenic resistance, but the human pseudogene is nonfunctional and has no physiological or pathological role[5][4]. - **Aliases:** Alternate identifiers and previous gene cards records exist, but all refer to inactive or uncharacterized sequences[2]. - **No molecular family:** As a pseudogene, it does not belong to transporter, enzyme, receptor, or other protein families. Summary assessment: - This gene is **not a functional target**, has **no biological or therapeutic relevance**, and is **considered a pseudogene with no product** in humans[2]. - The bacterial ArsA ATPase does have mechanistic and structural characterization as part of ATP-driven arsenite/antimonite efflux in prokaryotes, but no such transporter exists for this locus in humans[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ArsA arsenite transporter, ATP-binding, homolog 1, pseudogene (ArsA (pseudogene)).